Bill > HF2047

This bill requires health carriers (including pharmacy benefit managers) to reduce an enrollee's out-of-pocket prescription drug costs at the point of sale by passing along 100% of rebates received from drug manufacturers or pharmacies. The bill defines several key terms, including "rebate" as negotiated price concessions and "defined cost-sharing" as the deductible or coinsurance an enrollee pays for a prescription drug. To protect the financial interests of health carriers, the bill mandates strict confidentiality around rebate information, prohibiting disclosure of specific rebate amounts or details that could reveal sensitive financial data. Health carriers that fail to comply with these requirements may face sanctions, including civil penalties and potential suspension or revocation of their license. The legislation aims to make prescription drugs more affordable for consumers by ensuring that negotiated discounts and rebates directly benefit patients at the time of purchase, rather than being retained by health carriers or pharmacy benefit managers.

Business and Industry

https://www.revisor.mn.gov/bills/bill.php?b=House&f=HF2047&ssn=0&y=2025